返回 Agenda
Session 10 Track 2: Artificial Intelligence (AI): The Next Frontier
Session Chair(s)
Brooke Casselberry, MS, RAC
Vice President, Advisory and Delivery
Epista Life Sciences, United States
This session will provide an overview of Artificial Intelligence (AI) technologies such as robotic process automation (RPA), natural language processing (NLP), and machine learning, and offer insight into how these AI technologies are developed and applied to regulatory affairs. Speakers will share their recent experience with implementing AI projects, their decision processes, and lessons learned along the way.
Learning Objective : At the conclusion of this session, participants should be able to:
- Define basic AI terminology
- Provide examples of application to regulatory technology
- Describe common challenges to implementing AI
Speaker(s)
Smart Regulatory Affairs: From Document Creation to Supported Decision-Making
Adair Turner, MSc, RAC
Cencora Pharmalex, United States
Sr. Director, Head of Regulatory Affairs US
Using Artificial Intelligence to Augment Regulatory Affairs Knowledge
Nicholas Drago, MS, RAC
Bayer, United States
Associate Director, Global Regulatory Strategy
A Journey from Automation to AI within Regulatory Operations
Cesar Vinces
Accumulus Synergy, United States
EU Interim and International Policy Lead